对FDA不良事件报告系统事件的不成比例分析,用于mizoprostol
1Department of Obstetrics and Gynaecology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, China.
Scientific reports
|January 19, 2025
概括
这项研究分析了FDA的数据,以确定mizoprostol不良事件 (AE). 检测到新的安全信号,包括先天性脑损伤,需要仔细的临床评估和监测.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 生殖医学 生殖医学
背景情况:
- 弥苏,最初用于胃,广泛用于产科和妇科.
- 与mizoprostol使用相关的未检测到的不良事件 (AEs) 仍然令人担忧.
- 全面的安全数据对于明智的临床决策至关重要.
研究的目的:
- 进行对mizoprostol的全面安全概述.
- 为了识别和分析报告的对mizoprostol的不良事件 (AEs).
- 检测超出既定药物信息的新安全信号.
主要方法:
- 使用了FDA不良事件报告系统 (FAERS) 数据库 (2004年第一季度2024年第二季度).
- 采用比例失衡方法:报告赔率比率 (ROR),比例报告比率 (PRR),贝叶斯信心传播神经网络 (BCPNN) 和经验贝叶斯几何平均值 (EBGM).
- 分析了超过1740万份不良事件报告,以确定与mizoprostol相关的事件.
主要成果:
- 在23个器官系统类别和30个首选术语中,确定了2032份与mizoprostol相关的不良事件报告.
- 最常见的副作用包括分娩期间的胎儿暴露,子宫快囊缩,子宫破裂和心率下降.
- 检测到新的潜在安全信号:先天性水道狭窄和先天性脑损伤.
结论:
- 米索普罗斯托尔的使用与各种不良事件有关,其中一些以前未被识别.
- 新的安全信号需要进一步调查和临床警.
- 临床医生必须仔细评估患者,监测AEs,并为潜在的不良结果做好准备.
更多相关视频
07:36Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
1.5K
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
9.7K
相关概念视频
01:19Pharmacovigilance
770
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
770
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
337
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
337
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
115
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
115
01:12Hazard Ratio
83
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
83